{
  "title": "Covid Vaccine Front-Runner Ahead of Competition",
  "itunes:title": "Covid Vaccine Front-Runner Ahead of Competition",
  "description": "<p>The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. Could this be the one?</p><p>Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. Could this be the one?</p><p>Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "67243c18-c875-11ea-aa4b-ff0f9e8d22da",
  "omny:clipId": "26b290b9-b5ff-424c-8b13-ae2b00647efb",
  "pubDate": "Fri, 17 Jul 2020 21:37:01 +0000",
  "itunes:duration": 1701,
  "enclosure": "",
  "link": "https://omny.fm/shows/bloomberg-businessweek/covid-vaccine-front-runner-ahead-of-competition"
}